The PennZone

  • Home
  • Non-profit
  • Health
  • Books
  • Marketing
  • Entertainment
  • Sports
  • Business
  • Legal

Electroshock and Antidepressants: Hidden Dangers in Misdiagnosed Holiday Blues
The PennZone/10291181

Trending...
  • Communities In Schools of Eastern Pennsylvania Honors United Way and Local Leaders
  • Conservative Latinos for PA PAC Endorses Stacy Garrity for Governor: "Pennsylvania's Latino Families Need a Leader Who Delivers"
  • ALight Technology And Services Limited Advances Through Peachscore + Dealum Accelerator and Join LvlUp Labs
ECT and Antidepressants: Hidden Dangers
A new study reveals widespread misinformation about electroshock therapy among patients. CCHR says parents are similarly misled about ECT use on teens and children as young as five. Moreover, antidepressants—often a precursor to ECT recommendations—also carry significant risks.

LOS ANGELES - PennZone -- A new study reveals that patients feel misinformed about the risks of electroconvulsive therapy (ECT), reinforcing the argument that the practice should be banned, according to mental health industry watchdog, Citizens Commission on Human Rights International. Study participants shared accounts of immediate cognitive and memory impairments, as well as long-term effects such as profound loss of abilities, memory, humanity, and personal connections, along with psychological harm and a sense of brain damage. Published in Qualitative Health Research, the study highlights that many patients are denied recognition of their adverse outcomes, which intensifies their struggles.[1]

CCHR says that in the U.S., young teens and children under six have undergone ECT. Lacking the ability to consent, parents—often misinformed about its safety and efficacy—agree to the practice. They are likely unaware that no clinical trials have substantiated safety and efficacy.

The information leaflets provided to patients regarding ECT have been found to minimize the prevalence or severity of memory loss, researchers found. The study says, "Following ECT, there is a possibility of permanent adverse effects including memory and cognitive impairment" and that "Iatrogenic harm, the infliction of harm through medical interventions, is a known possible outcome of ECT."

While the survey of consumers occurred in the United Kingdom, CCHR says that similar patient complaints about ECT have been reported to the group in the U.S. and other countries. Recently, CCHR International supported groups helping a Minnesota man who was threatened with court-ordered ECT when he refused to consent to it. The man had already received 17 courses of involuntary shock and was terrified of undergoing more.

More on The PennZone
  • Hope Survives Announces Hidden Impact, Its Second Brain Injury Podcast
  • Household Staffing Recognized as Principal Benefactor of the Nanny Relief Fund
  • KOLBUS America, For All Of Your Hycorr Equipment And Service Needs
  • Heritage at Hopewell Announces New 3.875% Year-One Mortgage Rate Buydown Incentive on Quick Delivery Townhomes (7.11% APR)
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc

In its letter to the psychiatric hospital attempting to force ECT upon the 44-year-old man, CCHR cited numerous United Nations reports that say involuntary, forced electroshock constitutes torture and that U.S. courts have acknowledged ECT's risks to patients, including brain damage, memory loss, and cognitive disability.[2]

ECT is often recommended when other treatments have not worked, especially antidepressants. These drugs also have iatrogenic side effects. The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) is currently reviewing safety alerts for 30 antidepressants, after Thomas Kingston, husband of Lady Gabriella Kingston, daughter of Prince and Princess Michael of Kent, fatally shot himself due to adverse effects from these drugs.[3] A coroner ruled Mr. Kingston shot himself due to the adverse effect of the medications he had been prescribed, which included the common antidepressant citalopram. According to evidence given at his inquest, Mr. Kingston had complained that another antidepressant was making him anxious. A medical expert at the inquest, Dr David Healy, suggested this was a sign that SSRI antidepressants "did not suit him" and that he should not have been prescribed citalopram following this. "We need a much more explicit statement saying that these drugs can cause people to commit suicide who wouldn't have otherwise," he said.[4]

MHRA data shows 71 alerts since 2014 over deaths linked to citalopram and 114 for sertraline.[5]

According to JAMA Psychiatry, ECT is recommended after two antidepressants have failed as "first-line" treatments. CCHR says consumers are often misinformed and, therefore, are unaware that treatment side effects can drive them to have suicidal feelings. When these increase, they are further misled into believing it is their mental state "at fault," rather than the adverse mental and physical effects synonymous with both antidepressants and electroshock.

More on The PennZone
  • Rent a Truck or Hire Movers? New Data Shows Fuel Now Makes Up to 40% of DIY Moving Costs
  • TrueNorth Wellness Services Expands Rural Behavioral Health Care in Fulton County with Technology
  • Club Wyndham Research Identifies the "Holiday Rewind Effect": 93% of Parents Recreate Their Own Childhood Holidays for Their Kids
  • IEI Rugged IP66 Panel PC Brings Real-Time Visibility to Heavy-Duty Mining Fleets
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc

During the holiday season, CCHR is committed to raising awareness about individuals experiencing sorrow because of a lost one, loneliness, being away from family, and more. People can become unwitting candidates for having such emotions misdiagnosed as "holiday depression," and put at risk of being prescribed antidepressants. CCHR wants to see different, non-invasive approaches taken to help individuals and strongly urges against agreeing to electroshock therapy, recommending legal support if necessary to prevent it from being forced on any individual.

Founded 55 years ago by the Church of Scientology and psychiatrist Dr. Thomas Szasz, CCHR has achieved significant milestones in mental health reform. In 1976, it played a pivotal role in securing the first-ever prohibition on electroshocking minors in California. Similarly, in 2014, CCHR helped enact legislation in Western Australia that made administering ECT to minors a criminal offense. The organization was also instrumental in prompting the Food and Drug Administration to hold hearings on the potential suicidal effects of SSRI antidepressants, leading to the FDA issuing warnings of suicidal ideation for individuals under 24.
Sources:

[1] Emily Shipwright, David Murphy, "Long-Term Adverse Effects After Electroconvulsive Therapy (ECT): A Narrative Analysis Exploring People's Experiences, Meaning-Making, and Coping," Qualitative Health Research, 2024, journals.sagepub.com/doi/10.1177/10497323241303391

[2] "CCHR Supports Minnesota Man's Opposition to Enforced Electroshock Treatment," CCHR International, 4 Dec. 2024, www.cchrint.org/2024/12/04/cchr-supports-opposition-to-enforced-electroshock-treatment/

[3] "More than 100 alerts over deaths linked to antidepressants taken by Thomas Kingston," The Independent, 8 Dec. 2024, www.independent.co.uk/news/health/antidepressant-citalopram-thomas-kingston-b2658665.html

[4] "More than 100 alerts over deaths linked to antidepressants taken by Thomas Kingston," The Independent, 8 Dec. 2024, www.independent.co.uk/news/health/antidepressant-citalopram-thomas-kingston-b2658665.html

[5] "More than 100 alerts over deaths linked to antidepressants taken by Thomas Kingston," The Independent, 8 Dec. 2024, www.independent.co.uk/news/health/antidepressant-citalopram-thomas-kingston-b2658665.html

Contact
CCHR International
***@cchr.org


Source: Citizens Commission on Human Rights
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Tampa Web Design Launches New Website for Entrepreneur and Capital Markets Advisor Martin Sumichrast
  • Miami Dade College and World Affairs Council of Miami announce Navarro-Cabrera scholarship
  • Bridging Canvas and Cosmos: How Bioengineer Farin DeBose Captured the Essence of "True Science"
  • RPP to host first Professional Padel Week in Miami and announce the 2026 USA Awards winners
  • UK Financial Ltd. Announces Maya Preferred PRA as First Fully Verified Asset on MAYA CHAIN; Chainlink Proof of Reserve Integration Planned for Network
  • ALight Technology And Services Limited Advances Through Peachscore + Dealum Accelerator and Join LvlUp Labs
  • NAO Releases Shopping Intelligence to Streamline Your Quest for Value
  • International Misophonia Foundation Launches Sensory Accessible Technology Initiative to Address Overlooked Digital Accessibility Barriers
  • The Robert Travers Team of Long & Foster Marks 300+ Homes Sold, Expands Seller Representation
  • CLINIMED Becomes First Liposuction Cannula Maker to Offer 3D and AR Models of Its Cannula Range
  • RAS AP Consulting Advances 1099 Education and Readiness Initiative Through IFOL Training and Finance Technology Showcase
  • Heritage at Manalapan Announces New 3.875% First-Year Mortgage Rate Buydown (7.11 APR)
  • Conservative Latinos for PA PAC Endorses Stacy Garrity for Governor: "Pennsylvania's Latino Families Need a Leader Who Delivers"
  • AthleteMerch.com Surpasses 100,000 Custom Items Delivered to Fans Nationwide
  • MoMojo Records Signs Gary Nicholson
  • Steve Weclew is Appointed by STS Capital Partners as Managing Director
  • Communities In Schools of Eastern Pennsylvania Honors United Way and Local Leaders
  • New Finnish Affiliate Site Ilmaiskierrokset.com Puts Wager-Free Spins in the Spotlight
  • Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
  • Veterans Day Breakfast Celebration in Valley Forge to Honor America's Military Heroes

Popular on PennZone

  • SMACK Fighting Championships Announces Influencer Fight Night at Harrah's Philadelphia - 225
  • ASSIST Software Wins Volkswagen Challenge for Automated Quality Inspection - 112
  • RAS AP Consulting Issues National Compliance Alert and Launches Q4 2026 AP Readiness Program Ahead of IRS FIRE → IRIS Cutover - 107
  • New Children's Picture Book "Tippy Tay" Explores the Dangers of Peer Pressure and the Importance of - 107
  • New Children's Picture Book "Adam's Apple" Celebrates Childhood Curiosity and the Funny Misundersta - 105
  • Free Senior Housing Webinar Helps Families Plan for Aging Before a Crisis Forces Difficult Decisions
  • LS2 Partners with Angels Of Dirt's "Next Chapter Racer" Series Celebrating Women and Girls in Motorsports
  • What Mold Remediation Costs in Gettysburg, PA: 2026 Price Ranges by Job Type
  • Creole101 Launches Multilingual Dictionary App with 50,000+ Entries, Vocabulary Games and Haitian Cultural Resources
  • Pittsburgh Digital Marketing Agency Moves to Babcock Boulevard in the North Hills

Similar on PennZone

  • Household Staffing Recognized as Principal Benefactor of the Nanny Relief Fund
  • KOLBUS America, For All Of Your Hycorr Equipment And Service Needs
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • Rent a Truck or Hire Movers? New Data Shows Fuel Now Makes Up to 40% of DIY Moving Costs
  • TrueNorth Wellness Services Expands Rural Behavioral Health Care in Fulton County with Technology
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
  • Award-Winning American Hotelier Opens Art-Filled Luxury Cottage in Norfolk, England
  • Ten Ten Ten Announces Maximizing Quality Performance, a Value-Based Care Implementation Guide
  • Tampa Holiday Sessions: Captured by Mallary Opens 2026 Christmas Minis With Two New Sets
  • Bridging Canvas and Cosmos: How Bioengineer Farin DeBose Captured the Essence of "True Science"
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us